Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment

NCT05717582 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer
Castration-Sensitive Prostate Cancer

Interventions

DRUG: apalutamide
DRUG: androgen deprivation therapy
PROCEDURE: cytoreductive radical prostatectomy with/without pelvic lymph node dissection
RADIATION: metastasis-directed therapy with radiation

Sponsor

Fudan University